Lapatinib
CAS 231277-92-2
Em Estoque
Lapatinib
Cat. No. STUB-API-LAPATINIBCAS 231277-92-2Em Estoque
Dados Técnicos
Cat. No.STUB-API-LAPATINIB
CAS231277-92-2
Fórmula Mol.C29H26ClFN4O4S
Peso Mol.581.069 g/mol
IUPACN-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine
SMILESCS(=O)(=O)CCNCC1=CC=C(O1)C2=CC3=C(C=C2)N=CN=C3NC4=CC(=C(C=C4)OCC5=CC(=CC=C5)F)Cl
InChIInChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)
Chave InChIBCFGMOOMADDAQU-UHFFFAOYSA-N
Pureza—
Descrição
Visão geral
Lapatinib is an anti-cancer drug developed by GlaxoSmithKline (GSK) as a treatment for solid tumours such as breast and lung cancer
A Anant Labs fabrica e fornece impurezas de Lapatinib de alta qualidade para o mercado global. Nossas impurezas EP de Lapatinib são utilizadas por fabricantes de APIs e empresas farmacêuticas totalmente integradas em todo o mundo.
Sinônimos
Lapatinib231277-92-2GW572016GW 572016GW-572016GSK 572016DTXSID7046675n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamineGSK-5720160VUA21238F
